中医临床路径管理在风痰阻络型急性缺血性中风患者中的应用  

Clinical Pathway Management in Acute Ischemic Stroke Patients with Wind Phlegm Blocking Collaterals

作　　者：曾永青[1] 尹璇[1] 黄伟亮 ZENG Yongqing;YIN Xuan;HUANG Weiliang(Huizhou Third People's Hospital,Huizhou 516000,Guangdong,China)

机构地区：[1]惠州市第三人民医院,广东惠州516000

出　　处：《实用中医内科杂志》2022年第6期119-121,共3页Journal of Practical Traditional Chinese Internal Medicine

基　　金：广东省中医药局科研项目(20202212)。

摘　　要：目的观察临床路径管理在风痰阻络型急性缺血性中风患者中的应用价值。方法选取惠州市第三人民医院中医科住院患者73例,将患者随机分为对照组及观察组,对照组选择经验性用药,观察组根据科室的实际情况设计中风-中经络(风痰阻络证)的临床路径文本,并按临床路径方案进行诊疗,观察两组患者的卒中量表评价情况、医疗资源消耗、中医证候积分变化、不良反应发生情况。结果治疗后,观察组卒中量表评价得分优于对照组(P<0.05),中医证候积分的主症与合计积分无差异,但观察组次症积分优于对照组(P<0.05);观察组平均住院时间为(7.18±1.52)d,平均住院总费用为(7871.48±2551.34)元,均优于对照组(P<0.05)。结论将临床路径管理应用于中医风痰阻络型急性缺血性中风的治疗中,可以更好地做到治疗工作的同质化,从而提高整体的治疗效果,同时有效的控制医疗资源消耗、提高医疗资源的利用率。Objective To observe the application value of clinical pathway management in patients with acute ischemic stroke of wind phlegm blocking collaterals.Methods Seventy-three patients in the Department of Traditional Chinese Medicine of Huizhou Third People’s hospital were randomly divided into control group and observation group.The control group was treated with empirical drugs.The observation group designed the clinical path text of stroke(wind phlegm blocking meridian syndrome)according to the actual situation and made diagnosis and treatment according to the clinical path scheme,and then the stroke scale,the consumption of medical resources,the change of TCM symptom score and the occurrence of adverse reactions of the two groups were observed.Results After treatment,the score of stroke scale in the observation group was better than that in the control group(P<0.05).There was no difference between the main symptom score and the total score of TCM symptom score,but the secondary symptom score in the observation group was better than that in the control group(P<0.05).The average length of stay in the observation group was(7.18±1.52)days and the average total cost of hospitalization was(7871.48±2551.34)yuan,which were better than those in the control group(P<0.05).Conclusion The application of clinical pathway management in the treatment of acute ischemic stroke with wind phlegm blocking collaterals in traditional Chinese medicine can better achieve the homogenization of treatment work,so as to improve the overall treatment effect,effectively control the consumption of medical resources and improve the reasonable utilization rate of medical resources.

关 键 词：临床路径 风痰阻络 急性缺血性中风 临床观察 

分 类 号：R255.2[医药卫生—中医内科学]